Imaging in the era of molecular oncology
By Ralph Weissleder, M. Pittet. Nature, 2008
2,272 citations recorded by the source corpus.
Subfields: Biomedical Engineering, Biophysics, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/cbdf6f1725dd0288ee9d8051242a157f458b6ea1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomedical Engineering
- Isaac Koh
- Lee Josephson
- Vasilis Ntziachristos
- Ralph Weissleder
- Miqin Zhang
- M. Pittet
- Omid Veiseh
- J. Gunn
In Biophysics
In Pulmonary and Respiratory Medicine
- Lee Josephson
- Isaac Koh
- Vasilis Ntziachristos
- Ralph Weissleder
- Miqin Zhang
- D. Hanahan
- Lisa M. Coussens
- Ron M. A. Heeren
Citations in the corpus
- Luminescent materials incorporating pyrazine or quinoxaline moieties (2013, background): “[9] a) Weissleder R, Pittet MJ, Imaging in the era of molecular oncology Nature 2008;452:580–9.”
- Sol-gel based materials for biomedical applications (2016, background): “Each imaging modality has its own unique advantages along with intrinsic limitations (such as insufficient sensitivity or spatial resolution) which make it difficult to obtain accurate and reliable information at the disease site [537].”
- Origins of tumor-associated macrophages and neutrophils (2012, methodology): “The spleen was exposed surgically and kept moist during imaging as previously described (2), and it was imaged with an Olympus objective (0.”
- Relative and absolute determination of fluorescence quantum yields of transparent samples (2013, background): “For higher precision, the band-pass ∆λex used for excitation can be considered according to equation (4).”
- Going deeper than microscopy: the optical imaging frontier in biology (2010, background): “Here I review established and emerging photonic methods, focusing on methodologies that can perform in vivo molecular imaging, that is, in vivo imaging of optical reporters such as fluorescent probes, fluorescent proteins and other chromophoric agents and nanoparticles that can be used to label ”
- Systems medicine: the future of medical genomics and healthcare (2009, background): “imaging [233], and bio-banking that complies with strictly enforced ethical regulations [234-236].”